Correct Answer: A. Start ART immediately and continue life-long
HIV-positive pregnant women require immediate initiation of antiretroviral therapy (ART) regardless of trimester, CD4 count, or viral load status. This is the standard of care per WHO, NACO (National AIDS Control Organization), and Indian guidelines. The rationale is two-fold: (1) maternal health: ART reduces maternal morbidity and mortality by suppressing viral replication and preserving immune function; (2) prevention of mother-to-child transmission (PMTCT): undetectable viral load (achieved through immediate ART) reduces MTCT risk to <1–2%, whereas delayed initiation leaves the fetus exposed during critical organogenesis in the first trimester. The myth that ART is teratogenic in the first trimester is outdated; modern antiretrovirals (NRTIs, NNRTIs, PIs, INSTIs) are safe throughout pregnancy when used as per NACO guidelines. ART must be continued life-long because HIV is a chronic infection requiring indefinite suppression; stopping ART post-delivery (as suggested in other options) leads to viral rebound, immune collapse, and increased risk of opportunistic infections in the mother. The "undetectable = untransmittable" principle (U=U) is now globally accepted and endorsed by NACO: a woman with undetectable viral load on ART poses negligible risk of sexual transmission and vertical transmission.
Why the other options are wrong
B. Start ART after 1st trimester and continue till 6 weeks after delivery — This is wrong on two counts: (1) Delayed initiation until 2nd trimester leaves the fetus exposed during the critical period of organogenesis in the 1st trimester, increasing MTCT risk; (2) Stopping ART at 6 weeks post-delivery is dangerous—it causes rapid viral rebound, CD4 decline, and maternal opportunistic infections. NACO guidelines mandate life-long ART continuation. This option conflates outdated practices with modern evidence. C. Start ART after 1st trimester and continue life-long — While life-long continuation is correct, delaying ART initiation until the 2nd trimester is the critical error. The 1st trimester is when organogenesis occurs and MTCT risk is highest if viral load is uncontrolled. Immediate initiation (from diagnosis) is superior because it achieves viral suppression faster and protects the fetus during the most vulnerable period. This option represents a compromise that sacrifices fetal safety. D. Start ART immediately and continue till 6 weeks after delivery — Immediate ART initiation is correct, but stopping ART at 6 weeks post-delivery is contraindicated. HIV is a chronic infection; ART must be continued indefinitely to maintain immune function and prevent maternal disease progression. Stopping ART leads to viral rebound within weeks, CD4 decline, and risk of TB, PCP, and other opportunistic infections—especially dangerous in the postpartum period when the mother is immunologically stressed.
High-Yield Facts
- Immediate ART initiation is indicated for all HIV-positive pregnant women regardless of CD4 count, viral load, or trimester (NACO, WHO 2021 guidelines).
- MTCT risk is <1–2% when maternal viral load is undetectable (<50 copies/mL) on ART; delayed initiation increases risk during organogenesis in 1st trimester.
- Teratogenicity myth: Modern antiretrovirals (TDF/FTC, EFV, DTG, LPV/r) are safe in all trimesters; the fear of 1st-trimester exposure is outdated.
- Life-long ART is mandatory; stopping ART post-delivery causes viral rebound, CD4 collapse, and maternal opportunistic infections within weeks.
- U=U principle: Undetectable viral load on ART = untransmittable; this eliminates both sexual and vertical transmission risk.
Mnemonics
START ART ASAP (Pregnant HIV+) Start immediately (not after 1st trimester) | ART for All (regardless of CD4) | Suppress viral load (MTCT prevention) | ART Permanently (life-long, not till 6 weeks post-delivery). Use this when deciding timing and duration of ART in pregnancy. PMTCT = Prompt + Persistent Prompt ART initiation (from diagnosis, any trimester) + Persistent ART continuation (life-long) = Prevention of Mother-to-Child Transmission. Eliminates the trap of delayed start or early stop.
NBE Trap
NBE commonly pairs "1st trimester" with "teratogenicity concern" to lure students into choosing delayed ART initiation (options B or C). The trap exploits outdated fear of antiretroviral drugs in early pregnancy, when in fact modern ART is safe and immediate initiation is protective for both mother and fetus.
Clinical Pearl
In Indian public health settings, many HIV-positive women present late in pregnancy or at delivery. Immediate ART initiation at first diagnosis—even if in the 1st trimester—is the single most effective intervention to prevent vertical transmission and improve maternal survival. A woman on undetectable ART can have a healthy pregnancy and deliver a HIV-negative baby; delaying ART is never justified.
_Reference: NACO Guidelines on Prevention of Parent-to-Child Transmission (PPTCT) 2021; Harrison Ch. 197 (HIV/AIDS); DC Dutta's Obstetrics (HIV in Pregnancy section)_